Point72 Asset Management, L.P. - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q2 2022$1,240,000
+90.2%
1,000,0000.0%0.01%
+66.7%
Q1 2022$652,000
-40.2%
1,000,0000.0%0.00%
-25.0%
Q4 2021$1,090,000
-56.3%
1,000,000
-27.0%
0.00%
-63.6%
Q3 2021$2,493,000
+421.5%
1,369,900
+3339.9%
0.01%
+266.7%
Q2 2015$478,00039,8240.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 12,546,493$22,835,0001.71%
MSD Partners, L.P. 15,151,516$27,576,0000.84%
MSD Partners, L.P. 7,575,758$13,788,0000.42%
CHIRON CAPITAL MANAGEMENT, LLC 198,002$360,0000.26%
Avidity Partners Management LP 3,000,000$5,460,0000.12%
Old West Investment Management, LLC 211,513$384,0000.10%
MAGNOLIA CAPITAL ADVISORS LLC 103,239$188,0000.07%
Virtus ETF Advisers LLC 72,060$131,0000.06%
ACT WEALTH MANAGEMENT, LLC 34,454$91,0000.06%
Allred Capital Management, LLC 53,000$96,0000.05%
View complete list of ZIOPHARM ONCOLOGY INC shareholders